Pegvaliase
Palynziq (pegvaliase) is an enzyme pharmaceutical. Pegvaliase was first approved as Palynziq on 2018-05-24. It is used to treat phenylketonurias in the USA. It has been approved in Europe to treat phenylketonurias.
| Trade Name | Palynziq |
|---|---|
| Common Name | Pegvaliase |
| Indication | phenylketonurias |
| Drug Class | Enzymes; PEGylated compounds |
